Cargando…

IL-33-mediated activation of mast cells is involved in the progression of imiquimod-induced psoriasis-like dermatitis

BACKGROUND: Psoriasis is a chronic inflammatory dermatosis with an unclear pathogenesis. Mast cells (MCs) can serve as a bridge between innate and adaptive immunity and are involved in the regulation of the inflammatory state and immune homeostasis in diseases. MCs constitutively express interleukin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xuyue, Hu, Yu, Liu, Lingxi, Liu, Lihao, Chen, Hongying, Huang, Dan, Ju, Mei, Luan, Chao, Chen, Kun, Zhang, Jiaan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996901/ https://www.ncbi.nlm.nih.gov/pubmed/36894987 http://dx.doi.org/10.1186/s12964-023-01075-7

Ejemplares similares

Landscape of circulating metabolic fingerprinting for keloid
por: Hu, Yu, et al.
Publicado: (2022)

Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33
por: Athari, Sara Khaleghparast, et al.
Publicado: (2016)

IDO-expressing Fibroblasts Suppress the Development of Imiquimod-induced Psoriasis-like Dermatitis
por: Elizei, Sanam Salimi, et al.
Publicado: (2018)

Augmentation of NAD(+) by Dunnione Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
por: Lee, Seung Hoon, et al.
Publicado: (2022)

Dietary Fiber Inulin Improves Murine Imiquimod-Induced Psoriasis-like Dermatitis
por: Yoshida, Mai, et al.
Publicado: (2023)

Amelioration of imiquimod-induced psoriasis-like dermatitis in mice by DSW therapy inspired hydrogel
por: He, Xiang, et al.
Publicado: (2020)

Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients
por: Yen, Ling-Jung, et al.
Publicado: (2022)

Combination Therapy of Acarbose and Cyclosporine a Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice
por: Chen, Hsin-Hua, et al.
Publicado: (2020)

Lipoxin A4 Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis via Promoting the Regression of Inflammation
por: Hu, Feng, et al.
Publicado: (2023)

Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis
por: Xiao, Chun-Ying, et al.
Publicado: (2020)

Forsythoside A Alleviates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Regulating Th17 Cells and IL-17A Expression
por: Lin, Hsuan, et al.
Publicado: (2022)

Regulatory Mechanism of the IL-33–IL-37 Axis via Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis
por: Tsuji, Gaku, et al.
Publicado: (2023)

Antipsoriatic Effects of Wannachawee Recipe on Imiquimod-Induced Psoriasis-Like Dermatitis in BALB/c Mice
por: Na Takuathung, Mingkwan, et al.
Publicado: (2018)

Microbiota and IL-33/31 Axis Linkage: Implications and Therapeutic Perspectives in Atopic Dermatitis and Psoriasis
por: Bonzano, Laura, et al.
Publicado: (2023)

Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis
por: Liu, Jiang-Min, et al.
Publicado: (2021)

Whole-genome identification and construction of the lncRNA-mRNA co-expression network in patients with actinic keratosis
por: Luan, Chao, et al.
Publicado: (2022)

A Dietary Oxysterol, 7-Ketocholesterol, Exacerbates Imiquimod-Induced Psoriasis-like Dermatitis in Steatohepatitic Mice
por: Saga, Ayami, et al.
Publicado: (2022)

Transcriptomic Analysis of the Mechanisms for Alleviating Psoriatic Dermatitis Using Taodan Granules in an Imiquimod-Induced Psoriasis-like Mouse Model
por: Kuai, Le, et al.
Publicado: (2021)

The role of IL-33 and mast cells in allergy and inflammation
por: Saluja, Rohit, et al.
Publicado: (2015)

(R)-Salbutamol Improves Imiquimod-Induced Psoriasis-Like Skin Dermatitis by Regulating the Th17/Tregs Balance and Glycerophospholipid Metabolism
por: Liu, Fei, et al.
Publicado: (2020)

Magnolol may contribute to barrier function improvement on imiquimod-induced psoriasis-like dermatitis animal model via the downregulation of interleukin-23
por: Guo, Jiun-Wen, et al.
Publicado: (2021)

The Role of Gut Microbiome in Psoriasis: Oral Administration of Staphylococcus aureus and Streptococcus danieliae Exacerbates Skin Inflammation of Imiquimod-Induced Psoriasis-Like Dermatitis
por: Okada, Karin, et al.
Publicado: (2020)

IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis
por: Hou, Yuzhu, et al.
Publicado: (2018)

IL-33/13 Axis and IL-4/31 Axis Play Distinct Roles in Inflammatory Process and Itch in Psoriasis and Atopic Dermatitis
por: Bodoor, Khaldon, et al.
Publicado: (2020)

Mechanisms and Effects of Isorhamnetin on Imiquimod-Induced Psoriasiform Dermatitis in Mice
por: Wu, Chieh-Shan, et al.
Publicado: (2022)

Salvianolic Acid B in Microemulsion Formulation Provided Sufficient Hydration for Dry Skin and Ameliorated the Severity of Imiquimod-induced Psoriasis-like Dermatitis in Mice
por: Guo, Jiun-Wen, et al.
Publicado: (2020)

Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice
por: Sun, Jun, et al.
Publicado: (2013)

Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis
por: QIN, SI, et al.
Publicado: (2014)

Whole-genome identification and systematic analysis of lncRNA-mRNA co-expression profiles in patients with cutaneous basal cell carcinoma
por: Zhang, Jiaan, et al.
Publicado: (2021)

Mast cells as important regulators in the development of psoriasis
por: Zhou, Xu-Yue, et al.
Publicado: (2022)

Rapamycin Alleviates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy
por: Kim, Hye Ran, et al.
Publicado: (2021)

Comprehensive analysis of lncRNA-mRNAs co-expression network identifies potential lncRNA biomarkers in cutaneous squamous cell carcinoma
por: Hu, Yu, et al.
Publicado: (2022)

Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of Dermatitis
por: Chen, Yan, et al.
Publicado: (2015)

Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner
por: Alvarez, Pilar, et al.
Publicado: (2016)

Mast Cells Respond to Cell Injury through the Recognition of IL-33
por: Lunderius-Andersson, Carolina, et al.
Publicado: (2012)

Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A–Producing γδ T Cells
por: Zhang, Song, et al.
Publicado: (2021)

Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra
por: Conti, Pio, et al.
Publicado: (2021)

Immunological Memory in Imiquimod-Induced Murine Model of Psoriasiform Dermatitis
por: Fenix, Kevin, et al.
Publicado: (2020)

Shikonin inhibits CEBPD downregulation in IL-17-treated HaCaT cells and in an imiquimod-induced psoriasis model
por: Lan, Xiao-Ou, et al.
Publicado: (2020)

Potential Role of Probiotics in Ameliorating Psoriasis by Modulating Gut Microbiota in Imiquimod-Induced Psoriasis-Like Mice
por: Lu, Wenwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ppkvc5b5bgg64d23fnhqob4kj5